A citation-based method for searching scientific literature

Marc S Rendell. Expert Opin Pharmacother 2018
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.
Gary Tresadern, Andres A Trabanco, Laura Pérez-Benito, John P Overington, Herman W T van Vlijmen, Gerard J P van Westen. J Chem Inf Model 2017
6
100


Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
Gerard J P van Westen, Olaf O van den Hoven, Rianne van der Pijl, Thea Mulder-Krieger, Henk de Vries, Jörg K Wegner, Adriaan P Ijzerman, Herman W T van Vlijmen, Andreas Bender. J. Med. Chem. 2012
27
100

Phenylglucosides and the Na+/glucose cotransporter (SGLT1): analysis of interactions.
M P Lostao, B A Hirayama, D D Loo, E M Wright. J. Membr. Biol. 1994
60
100

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice.
Leonardo Spatola, Silvia Finazzi, Claudio Angelini, Marco Dauriz, Salvatore Badalamenti.  2018
10
100

LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice.
David R Powell, Melinda G Smith, Deon D Doree, Angela L Harris, Jennifer Greer, Christopher M DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G Carson,[...]. J. Pharmacol. Exp. Ther. 2017
12
100

Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring.
K Tsujihara, M Hongu, K Saito, H Kawanishi, K Kuriyama, M Matsumoto, A Oku, K Ueta, M Tsuda, A Saito. J. Med. Chem. 1999
56
100

Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets.
Gerard Jp van Westen, Remco F Swier, Isidro Cortes-Ciriano, Jörg K Wegner, John P Overington, Adriaan P Ijzerman, Herman Wt van Vlijmen, Andreas Bender.  2013
29
100

Non-systemic drugs: a critical review.
Dominique Charmot. Curr. Pharm. Des. 2012
38
100


Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.
Christine Clar, James Alexander Gill, Rachel Court, Norman Waugh. BMJ Open 2012
119
100

Sodium-glucose cotransport.
Søren Brandt Poulsen, Robert A Fenton, Timo Rieg. Curr. Opin. Nephrol. Hypertens. 2015
36
100

The mechanism of sodium and substrate release from the binding pocket of vSGLT.
Akira Watanabe, Seungho Choe, Vincent Chaptal, John M Rosenberg, Ernest M Wright, Michael Grabe, Jeff Abramson. Nature 2010
121
100

Biology of human sodium glucose transporters.
Ernest M Wright, Donald D F Loo, Bruce A Hirayama. Physiol. Rev. 2011
573
100

Intestinal SGLT1 in metabolic health and disease.
Anders Lehmann, Pamela J Hornby. Am. J. Physiol. Gastrointest. Liver Physiol. 2016
24
100

ChEMBL: a large-scale bioactivity database for drug discovery.
Anna Gaulton, Louisa J Bellis, A Patricia Bento, Jon Chambers, Mark Davies, Anne Hersey, Yvonne Light, Shaun McGlinchey, David Michalovich, Bissan Al-Lazikani,[...]. Nucleic Acids Res. 2012
100


Inhibitor binding mode and allosteric regulation of Na+-glucose symporters.
Paola Bisignano, Chiara Ghezzi, Hyunil Jo, Nicholas F Polizzi, Thorsten Althoff, Chakrapani Kalyanaraman, Rosmarie Friemann, Matthew P Jacobson, Ernest M Wright, Michael Grabe. Nat Commun 2018
8
100

Development of SGLT1 and SGLT2 inhibitors.
Timo Rieg, Volker Vallon. Diabetologia 2018
46
100


The ChEMBL bioactivity database: an update.
A Patrícia Bento, Anna Gaulton, Anne Hersey, Louisa J Bellis, Jon Chambers, Mark Davies, Felix A Krüger, Yvonne Light, Lora Mak, Shaun McGlinchey,[...]. Nucleic Acids Res. 2014
669
100

The ChEMBL database in 2017.
Anna Gaulton, Anne Hersey, Michał Nowotka, A Patrícia Bento, Jon Chambers, David Mendez, Prudence Mutowo, Francis Atkinson, Louisa J Bellis, Elena Cibrián-Uhalte,[...]. Nucleic Acids Res. 2017
399
100

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.
B Komoroski, N Vachharajani, Y Feng, L Li, D Kornhauser, M Pfister. Clin. Pharmacol. Ther. 2009
226
100

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard,[...]. Diabetes 2012
332
100


Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect.
Philipp F Secker, Sascha Beneke, Nadja Schlichenmaier, Johannes Delp, Simon Gutbier, Marcel Leist, Daniel R Dietrich. Cell Death Dis 2018
13
100

Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes.
Nicole C Goodwin, Zhi-Ming Ding, Bryce A Harrison, Eric D Strobel, Angela L Harris, Melinda Smith, Andrea Y Thompson, Wendy Xiong, Faika Mseeh, Debra J Bruce,[...]. J. Med. Chem. 2017
19
100

SLC transporters as therapeutic targets: emerging opportunities.
Lawrence Lin, Sook Wah Yee, Richard B Kim, Kathleen M Giacomini. Nat Rev Drug Discov 2015
188
100

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
Fabian Sievers, Andreas Wilm, David Dineen, Toby J Gibson, Kevin Karplus, Weizhong Li, Rodrigo Lopez, Hamish McWilliam, Michael Remmert, Johannes Söding,[...]. Mol. Syst. Biol. 2011
100

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
106
100

QSAR applicabilty domain estimation by projection of the training set descriptor space: a review.
Joanna Jaworska, Nina Nikolova-Jeliazkova, Tom Aldenberg. Altern Lab Anim 2005
203
100

Structure-based identification of OATP1B1/3 inhibitors.
Tom De Bruyn, Gerard J P van Westen, Adriaan P Ijzerman, Bruno Stieger, Peter de Witte, Patrick F Augustijns, Pieter P Annaert. Mol. Pharmacol. 2013
68
100

Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.
Gerard J P van Westen, Jörg K Wegner, Peggy Geluykens, Leen Kwanten, Inge Vereycken, Anik Peeters, Adriaan P Ijzerman, Herman W T van Vlijmen, Andreas Bender. PLoS ONE 2011
28
100

Activity, assay and target data curation and quality in the ChEMBL database.
George Papadatos, Anna Gaulton, Anne Hersey, John P Overington. J. Comput. Aided Mol. Des. 2015
40
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.